Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC Read more about Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC
Thermal Imaging as a Potential Diagnostic Tool of Nasal Airflow Read more about Thermal Imaging as a Potential Diagnostic Tool of Nasal Airflow
Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001 Read more about Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001
Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery Read more about Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD) Read more about Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction Read more about Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma Read more about A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma
A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer Read more about A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer
Vitamin D to Improve Outcomes by Leveraging Early Treatment Read more about Vitamin D to Improve Outcomes by Leveraging Early Treatment
Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed Read more about Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed